Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Niger J Clin Pract ; 22(1): 92-100, 2019 Jan.
Article in English | MEDLINE | ID: mdl-30666026

ABSTRACT

OBJECTIVES: A prospective case-control study was carried out to assess the value of elastosonography in identifying endometrial pathology in women using Tamoxifen (TAM) for breast cancer. MATERIALS AND METHODS: In total, 66 women using TAM for breast cancer were enrolled for the study with 61 premenopausal and 61 postmenopausal healthy controls. Ultrasonographic findings (strain ratio, endometrial thickness) were evaluated in regard to the duration of TAM usage, histopathological findings, and menopausal status. RESULTS: Patients with endometrial cancer (EC) and cystic endometrial hyperplasia (CEH) were found to have longer duration of TAM usage, increased endometrial thickness, and higher strain ratios compared with controls. A significant positive correlation was found between duration of TAM usage, endometrial thickness, and the strain ratios. Endometrial thickness and the strain ratios were significant predictors for groups under risk. Cutoff values for endometrial thickness, strain ratios, and duration of TAM usage were 12.55 mm, 2.46, and 18 months in premenopausal group and 7.75 mm, 7.70, and 32 months in postmenopausal group to predict risky population, respectively. CONCLUSION: Endometrial tissue strain ratio was found to be significantly increased in cases with endometrial pathologies. Addition of elastosonography modality to B-mode may improve the diagnostic accuracy during the follow-up of women using TAM for breast cancer.


Subject(s)
Antineoplastic Agents, Hormonal/adverse effects , Breast Neoplasms/drug therapy , Elasticity Imaging Techniques/methods , Endometrial Hyperplasia/diagnostic imaging , Endometrial Neoplasms/diagnostic imaging , Endometrium/diagnostic imaging , Tamoxifen/adverse effects , Ultrasonography/methods , Adult , Aged , Aged, 80 and over , Antineoplastic Agents, Hormonal/therapeutic use , Breast Neoplasms/pathology , Case-Control Studies , Endometrial Hyperplasia/chemically induced , Endometrial Neoplasms/chemically induced , Endometrium/drug effects , Female , Humans , Middle Aged , Postmenopause , Premenopause , Prospective Studies , Tamoxifen/therapeutic use
2.
Allergy ; 69(2): 265-8, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24251444

ABSTRACT

A relationship between serum basal tryptase (sBT) levels, anaphylactic reactions, and clonal mast cell diseases was shown recently in adults with venom allergy, but the relationship between sBT levels and IgE-mediated food allergy and anaphylaxis is not known. In this study, children with food allergy (FA; n = 167) were analyzed in two groups according to the presence (FA+/A+; n = 79) or absence of anaphylaxis (FA+/A-; n = 88) and were compared with a control group (n = 113). Median sBT values in FA+/A+, FA+/A-, and control groups were 4.0 ng/ml (2.8-5.8), 3.6 (2.3-4.5), and 3.3 (2.4-4.4), respectively (P = 0.022). sBT measurements higher than the cutoff values of 5.7 and 14.5 were associated with 50% and 90% predicted probabilities, respectively, of moderate to severe anaphylaxis. Children with tree nuts/peanut allergies had significantly higher levels of sBT than children with milk and egg allergy (P = 0.022). Results suggest that sBT levels may predict moderate to severe anaphylaxis in children with food allergy, which may follow a particular pattern according to the food allergy phenotype.


Subject(s)
Anaphylaxis/blood , Anaphylaxis/enzymology , Food Hypersensitivity/blood , Food Hypersensitivity/enzymology , Tryptases/blood , Anaphylaxis/etiology , Biomarkers/blood , Child, Preschool , Female , Food Hypersensitivity/complications , Humans , Infant , Male , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...